Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global market revenue, 2015 - 2021(USD Million)
2.2. Global prosthetic heart valve market: Snapshot
Chapter 3. Prosthetic Heart Valve Market Global and Industry Analysis
3.1. Prosthetic heart valve: Market dynamics
3.2. Market drivers
3.2.1. Drivers of global prosthetic heart valve market: Impact analysis
3.2.2. Increasing prevalence of heart disorders
3.3. Market restraints
3.3.1. Restraints of global prosthetic heart valve market: Impact analysis
3.3.2. High cost of the therapy
3.4. Opportunities
3.4.1. Increasing demand from the emerging economies
3.4.2. Introduction of new techniques
3.5. Porters five forces analysis
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis by type segment
3.6.2. Market attractiveness analysis by regional segment
Chapter 4. Global Prosthetic Heart Valve Market - Competitive Landscape
4.1. Company market share, 2014
4.1.1. Global prosthetic heart valve market : company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Product Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Product and Regional Expansion
4.3. Product Portfolio
4.4. Patent Analysis (2011-2016)
4.4.1. Patent Trend
4.4.2. Patent Share by company
4.4.3. By Region
Chapter 5. Global Prosthetic Heart Valve Market Type Segment Analysis
5.1. Global prosthetic heart valve market: type overview
5.1.1. Global prosthetic heart valve market revenue share, by type, 2015 - 2021
5.2. Transcather valve
5.2.1. Global prosthetic heart valve market, by transcather valve, 2015 - 2021(USD Million)
5.3. Tissue valve
5.3.1. Global prosthetic heart valve market, by tissue valve, 2015 - 2021(USD Million)
5.4. Mechanical valve
5.4.1. Global prosthetic heart valve market, by mechanical valve, 2015 - 2021(USD Million)
Chapter 6. Global Prosthetic Heart Valve market Regional Segment Analysis
6.1. Global prosthetic heart valve market: Regional overview
6.1.1. Global prosthetic heart valve market revenue share by region, 2015 - 2021
6.2. North America
6.2.1. North America prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.2.2. U.S.
6.2.2.1. U.S. prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.3. Europe
6.3.1. Europe prosthetic heart valve market revenue, by a type, 2015 - 2021(USD Million)
6.3.2. Germany
6.3.2.1. Germany prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.3.3. France
6.3.3.1. France prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.3.4. UK
6.3.4.1. UK prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.4.2. China
6.4.2.1. China prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.4.3. Japan
6.4.3.1. Japan prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.4.4. India
6.4.4.1. India prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.5. Latin America
6.5.1. Latin America prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.5.2. Brazil
6.5.2.1. Brazil prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa prosthetic heart valve market revenue, by type, 2015 - 2021(USD Million)
Chapter 7. Company Profile
7.1. Colibri Heart Valve, LLC
7.1.1. Overview
7.1.2. Financials
7.1.3. Product portfolio
7.1.4. Business strategy
7.1.5. Recent developments
7.2. Cytograft Tissue Engineering, Inc. (CTE)
7.2.1. Overview
7.2.2. Financials
7.2.3. Product portfolio
7.2.4. Business strategy
7.2.5. Recent developments
7.3. Direct Flow Medical, Inc.
7.3.1. Overview
7.3.2. Financials
7.3.3. Product portfolio
7.3.4. Business strategy
7.3.5. Recent developments
7.4. Edwards Lifesciences LLC
7.4.1. Overview
7.4.2. Financials
7.4.3. Product portfolio
7.4.4. Business strategy
7.4.5. Recent developments
7.5. Heart Leaflet Technologies (HLT)
7.5.1. Overview
7.5.2. Financials
7.5.3. Product portfolio
7.5.4. Business strategy
7.5.5. Recent developments
7.6. Perouse Medical
7.6.1. Overview
7.6.2. Financials
7.6.3. Product portfolio
7.6.4. Business strategy
7.6.5. Recent developments
7.7. St. Jude Medical Inc.
7.7.1. Overview
7.7.2. Financials
7.7.3. Product portfolio
7.7.4. Business strategy
7.7.5. Recent developments
7.8. Sorin Group
7.8.1. Overview
7.8.2. Financials
7.8.3. Product portfolio
7.8.4. Business strategy
7.8.5. Recent developments
7.9. Symetis
7.9.1. Overview
7.9.2. Financials
7.9.3. Product portfolio
7.9.4. Business strategy
7.9.5. Recent developments
7.10. Transcatheter Technologies Gmbh
7.10.1. Overview
7.10.2. Financials
7.10.3. Product portfolio
7.10.4. Business strategy
7.10.5. Recent developments
7.11. On-X Life Technologies, Inc.
7.11.1. Overview
7.11.2. Financials
7.11.3. Product portfolio
7.11.4. Business strategy
7.11.5. Recent developments
7.12. Neovasc Inc.
7.12.1. Overview
7.12.2. Financials
7.12.3. Product portfolio
7.12.4. Business strategy
7.12.5. Recent developments
7.13. Micro Interventional Devices, Inc
7.13.1. Overview
7.13.2. Financials
7.13.3. Product portfolio
7.13.4. Business strategy
7.13.5. Recent developments
7.14. Leman Cardiovascular
7.14.1. Overview
7.14.2. Financials
7.14.3. Product portfolio
7.14.4. Business strategy
7.14.5. Recent developments
7.15. JenaValve Technology
7.15.1. Overview
7.15.2. Financials
7.15.3. Product portfolio
7.15.4. Business strategy
7.15.5. Recent developments
7.16. Boston Scientific Corporation
7.16.1. Overview
7.16.2. Financials
7.16.3. Product portfolio
7.16.4. Business strategy
7.16.5. Recent developments
7.17. Claret Medical, Inc.
7.17.1. Overview
7.17.2. Financials
7.17.3. Product portfolio
7.17.4. Business strategy
7.17.5. Recent developments
7.18. Medtronic, Inc.
7.18.1. Overview
7.18.2. Financials
7.18.3. Product portfolio
7.18.4. Business strategy
7.18.5. Recent developments
7.19. TTK Healthcare
7.19.1. Overview
7.19.2. Financials
7.19.3. Product portfolio
7.19.4. Business strategy
7.19.5. Recent developments
7.20. Braile Biomdica
7.20.1. Overview
7.20.2. Financials
7.20.3. Product portfolio
7.20.4. Business strategy
7.20.5. Recent developments
Chapter 8. Patents
8.1. U.S. (US Patents)
8.2. Europe (EP documents)
8.3. Japan (Abstracts of Japan)
8.4. Global (WIPO (PCT))